Announcements Trials

Browse Landscape

Status

Unknown 1 Terminated 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 2 Uterine Cervical Neoplasms 1 Tongue Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Salivary Gland Neoplasms 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Peripheral Nervous System Diseases 1 Oligodendroglioma 1 Neurotoxicity Syndromes 1 Neuritis 1 Neoplasms 1 Neoplasm Metastasis 1 Head and Neck Neoplasms 1 Gliosarcoma 1 Glioma 1 Glioblastoma 1 Esthesioneuroblastoma, Olfactory 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Brain Neoplasms 1 Astrocytoma 1

Interventions

Temozolomide 87 Bevacizumab 49 Radiotherapy 36 Irinotecan 22 Magnetic Resonance Spectroscopy 20 Surgical Procedures, Operative 17 Carboplatin 17 Carmustine 15 Radiation 12 Nivolumab 11 IL13-PE38 8 Erlotinib Hydrochloride 8 Thalidomide 7 Radiotherapy, Intensity-Modulated 7 Lomustine 7 Imatinib Mesylate 7 Everolimus 7 Aminolevulinic Acid 7 sargramostim 6 Topotecan 6 O(6)-benzylguanine 6 Cyclophosphamide 6 Chemotherapy, Adjuvant 6 vandetanib 5 temsirolimus 5 fluorodopa F 18 5 Vincristine 5 Surveys and Questionnaires 5 Radiosurgery 5 Flucytosine 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Glioma × Diffusion Tensor Imaging × Clear all

NCT03294434 2024-09-27

PRaM-GBM

Cambridge University Hospitals NHS Foundation Trust

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡